N-Asetil Sistein'in (NAC) En Önemli 9 Faydası скачать в хорошем качестве

N-Asetil Sistein'in (NAC) En Önemli 9 Faydası

Eczacı Farkıyla vitamin ve mineraller, ilaçlar, besin destekleri, kozmetik ürünlerle ilgili tüm bilgiler; ve topluma koruyucu halk sağlığı için bilgilendirme ve destek amacıyla sizlerleyiz... Bu videomda; N-asetil sisteinin yani NAC'nin en önemli 9 faydasından bahsediyorum Kaynaklar: 1. N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities. Bavarsad Shahripour R, Harrigan MR, Alexandrov AV.Brain Behav. 2014 Mar;4(2):108-22. doi: 10.1002/brb3.208. Epub 2014 Jan 13.PMID: 24683506 Free PMC article. Review. BACKGROUND: There is an expanding field of research investigating the benefits of medicines with multiple mechanisms of action across neurological disorders. ...NAC as a precursor to the antioxidant glutathione modulates glutamatergic, neurotrophic, and inflammatory 2. The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders. Bradlow RCJ, Berk M, Kalivas PW, Back SE, Kanaan RA.CNS Drugs. 2022 May;36(5):451-482. doi: 10.1007/s40263-022-00907-3. Epub 2022 Mar 22.PMID: 35316513 Free PMC article. Review. N-acetyl-L-cysteine (NAC) is a compound of increasing interest in the treatment of psychiatric disorders. ...However, most studies have been underpowered and perhaps too brief, with some evidence of benefit only after months of treatment with NAC. Currently 3. Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits. Rushworth GF, Megson IL.Pharmacol Ther. 2014 Feb;141(2):150-9. doi: 10.1016/j.pharmthera.2013.09.006. Epub 2013 Sep 28.PMID: 24080471 Review. 4. Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial. Morton D, Seymour M, Magill L, Handley K, Glasbey J, Glimelius B, Palmer A, Seligmann J, Laurberg S, Murakami K, West N, Quirke P, Gray R; FOxTROT Collaborative Group.J Clin Oncol. 2023 Mar 10;41(8):1541-1552. doi: 10.1200/JCO.22.00046. Epub 2023 Jan 19.PMID: 36657089 Free PMC article. 5. Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review. Calverley P, Rogliani P, Papi A.Drug Saf. 2021 Mar;44(3):273-290. doi: 10.1007/s40264-020-01026-y. Epub 2020 Dec 16.PMID: 33326056 Free PMC article. Review. N-Acetylcysteine (NAC) is widely used in respiratory medicine, with a maximum licensed dose in chronic use of 600 mg/day; however, some clinical trials have studied the efficacy of NAC at higher doses. The aim of this review was to evaluate the adverse effects profi 6. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM, Davern TJ 2nd, Murray NG, McCashland T, Reisch JS, Robuck PR; Acute Liver Failure Study Group.Gastroenterology. 2009 Sep;137(3):856-64, 864.e1. doi: 10.1053/j.gastro.2009.06.006. Epub 2009 Jun 12.PMID: 19524577 Free PMC article. Clinical Trial. BACKGROUND & AIMS: N-acetylcysteine (NAC), an antidote for acetaminophen poisoning, might benefit patients with non-acetaminophen-related acute liver failure. ...Patients with advanced coma grades do not benefit from NAC and typically require emerg 7. N-Acetylcysteine to Combat COVID-19: An Evidence Review. Shi Z, Puyo CA.Ther Clin Risk Manag. 2020 Nov 2;16:1047-1055. doi: 10.2147/TCRM.S273700. eCollection 2020.PMID: 33177829 8. N-acetylcysteine for non-acetaminophen induced acute liver failure: A review. Jiang SX, Hussaini T, Yoshida EM.Saudi J Gastroenterol. 2022 Mar-Apr;28(2):85-91. doi: 10.4103/sjg.sjg_406_21.PMID: 35142656 Free PMC article. Review. While NAC may have multiple mechanisms of action in treatment of ALF, this has not translated to clinical benefit. ...Multiple case studies and series have reported positive outcomes of NAC treatment for ALF of various etiologies. While prospective studies su … 9. Re-thinking lactation-related nipple pain and damage. Douglas P.Womens Health (Lond). 2022 Jan-Dec;18:17455057221087865. doi:10.1177/17455057221087865. PMID: 35343816 Free PMC article. Review. 10. Immunotherapy and breast cancer: an overview. Mezni E, Behi K, Gonçalves A.Curr Opin Oncol. 2022 Sep 1;34(5):587-594. doi: 10.1097/CCO.0000000000000878. Epub 2022 Jul 16.PMID: 35838204 Review. PURPOSE OF REVIEW: Recently, immune checkpoint inhibitors (ICI) have demonstrated survival benefits in triple-negative breast cancer (TNBC) patients, treated in both the advanced and the early settings. ...In the first-line setting, ICI in combination with chemotherapy hav … 11. https://primehealthdenver.com/nac-sup.... ----------- Yeni videolarımızı kaçırmamak için abone olmayı unutmayın ! ----------- Eczacı : E. Talip Önal Prodüksiyon : Lumos Ajans ----------- #eczacifarkiyla​​​​ #sağlık #humikasit